Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Fibroma × Hydroxyurea × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 7 Glioblastoma 6 Squamous Cell Carcinoma of Head and Neck 5 Gliosarcoma 5 Meningioma 4 Leukemia, Myeloid, Acute 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Head and Neck Neoplasms 4 Polycythemia Vera 3 Neoplasms 3 Leukemia, Myeloid, Chronic-Phase 3 Glioma 3 Primary Myelofibrosis 2 Myelodysplastic Syndromes 2 Leukemia 2 Laryngeal Neoplasms 2 Esophageal Neoplasms 2 Central Nervous System Neoplasms 2 Tongue Neoplasms 1 Thrombosis 1 Thrombocytosis 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Salivary Gland Neoplasms 1 Polycythemia 1 Pharyngeal Neoplasms 1 Paranasal Sinus Neoplasms 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1

Interventions

Triamcinolone Acetonide 1 Sodium Chloride 1 Imatinib Mesylate 1 Hydroxyurea 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00978146 2017-04-20

Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors

Children's Hospital of Philadelphia

Phase 2 Withdrawn

Fibroma, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡